Inflammatory bowel disease: past, present, and future

被引:182
作者
Sands, Bruce E.
机构
[1] Massachusetts Gen Hosp, MGH Crohns & Colitis Ctr, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02114 USA
关键词
Crohn's disease; ulcerative colitis; inflammatory bowel diseases; medical therapy; pathogenesis;
D O I
10.1007/s00535-006-1995-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Crohn's disease and ulcerative colitis, collectively known as the inflammatory bowel diseases (IBD), are largely diseases of the twentieth century, and are associated with the rise of modern, Westernized industrial society. Although the causes of these diseases remain incompletely understood, the prevailing model is that the intestinal flora drives an unmitigated intestinal immune response and inflammation in the genetically susceptible host. A review of the past and present of these diseases shows that detailed description preceded more fundamental elucidation of the disease processes. Working out the details of disease pathogenesis, in turn, has yielded dividends in more focused and effective therapy for IBD. This article highlights the key descriptions of the past, and the pivotal findings of current studies in disease pathogenesis and its connection to medical therapy. Future directions in the IBD will likely explicate the inhomogeneous causes of these diseases, with implications for individualized therapy.
引用
收藏
页码:16 / 25
页数:10
相关论文
共 101 条
[1]   Review Article: The genetics of inflammatory bowel disease [J].
Ahmad, T ;
Satsangi, J ;
Mcgovern, D ;
Bunce, M ;
Jewell, DP .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (06) :731-748
[2]   Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis [J].
Ardizzone, S ;
Maconi, G ;
Russo, A ;
Imbesi, V ;
Colombo, E ;
Porro, GB .
GUT, 2006, 55 (01) :47-53
[3]   Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype [J].
Arnott, IDR ;
Landers, CJ ;
Nimmo, EJ ;
Drummond, HE ;
Smith, BKR ;
Targan, SR ;
Satsangi, J .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2376-2384
[4]   Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis [J].
Arts, J ;
D'Haens, G ;
Zeegers, M ;
Van Assche, G ;
Hiele, M ;
D'Hoore, A ;
Penninckx, F ;
Vermeire, S ;
Rutgeerts, P .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (02) :73-78
[5]  
AZADKHAN AK, 1977, LANCET, V2, P892
[6]   ALPHA-4-BETA-7-INTEGRIN MEDIATES LYMPHOCYTE BINDING TO THE MUCOSAL VASCULAR ADDRESSIN MADCAM-1 [J].
BERLIN, C ;
BERG, EL ;
BRISKIN, MJ ;
ANDREW, DP ;
KILSHAW, PJ ;
HOLZMANN, B ;
WEISSMAN, IL ;
HAMANN, A ;
BUTCHER, EC .
CELL, 1993, 74 (01) :185-195
[7]   Gastrointestinal endritic cells play a role in immunity, tolerance, and disease [J].
Bilsborough, J ;
Viney, JL .
GASTROENTEROLOGY, 2004, 127 (01) :300-309
[8]   NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED INTESTINAL INFLAMMATION IN HUMANS [J].
BJARNASON, I ;
ZANELLI, G ;
SMITH, T ;
PROUSE, P ;
WILLIAMS, P ;
SMETHURST, P ;
DELACEY, G ;
GUMPEL, MJ ;
LEVI, AJ .
GASTROENTEROLOGY, 1987, 93 (03) :480-489
[9]   EFFECTS OF CIGARETTE-SMOKING ON THE CLINICAL COURSE OF ULCERATIVE-COLITIS [J].
BOYKO, EJ ;
PERERA, DR ;
KOEPSELL, TD ;
KEANE, EM ;
INUI, TS .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 (09) :1147-1152
[10]   Adalimumab induces and maintains clinical response and remission in patients with active Crohn's disease: Results of the CHARM Trial [J].
Colombel, J. ;
Sandborn, W. J. ;
Rutgeerts, P. ;
Enns, R. ;
Hanauer, S. B. ;
Remo, P. ;
Schreiber, S. ;
Lomax, K. G. ;
Pollack, P. F. .
GASTROENTEROLOGY, 2006, 131 (03) :950-950